borderline significancep = 0.051
MMR deficiency was associated with postmenopausal status, tumor grades 2–3, FIGO stages I–II ( p = 0.010, 0.011, 0.006), BMI < 25, and parous state (parity ≥ 1) with borderline significance ( p = 0.051, 0.064).
MMR deficiency was associated with postmenopausal status, tumor grades 2–3, FIGO stages I–II ( p = 0.010, 0.011, 0.006), BMI < 25, and parous state (parity ≥ 1) with borderline significance ( p = 0.051, 0.064).
Prognosis Cases with MMR deficiency showed a trend of poor progression-free survival (PFS) and overall survival (OS) ( p = 0.057, 0.076) ( Figure 3 A,B).
All analyses were conducted using SPSS version 23.0 (IBM, Armonk, NY, USA) and R software, version 3.2.5 for Windows (the R foundation for statistical computing, Vienna, Austria), and p -values < 0.05 were considered statistically significant; p -values between 0.05 and 0.15 were considered as a trend toward significance. 5.